Invention Grant
- Patent Title: Pharmaceutical composition for treating tumor
-
Application No.: US17563162Application Date: 2021-12-28
-
Publication No.: US12036204B2Publication Date: 2024-07-16
- Inventor: Taro Semba , Yasuhiro Funahashi , Takuya Suzuki
- Applicant: Eisai R&D Management Co., Ltd. , Ono Pharmaceutical Co., Ltd.
- Applicant Address: JP Tokyo
- Assignee: EISAI R&D MANAGEMENT CO., LTD.,ONO PHARMACEUTICAL CO., LTD.
- Current Assignee: EISAI R&D MANAGEMENT CO., LTD.,ONO PHARMACEUTICAL CO., LTD.
- Current Assignee Address: JP Tokyo; JP Osaka
- Agency: Morgan, Lewis & Bockius LLP
- Priority: JP 19138041 2019.07.26
- Main IPC: A61K31/357
- IPC: A61K31/357 ; A61K39/395 ; A61P35/00
Abstract:
A combined administration of a liposomal composition comprising Eribulin or a pharmaceutically acceptable salt thereof and a PD-1 antagonist exhibits unexpected antitumor effect.
Public/Granted literature
- US20220117933A1 Pharmaceutical Composition for Treating Tumor Public/Granted day:2022-04-21
Information query
